Noriyuki Kawamura

Title: Noriyuki Kawamura: Innovator in Depression Biomarkers

Introduction

Noriyuki Kawamura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of mental health through his innovative research on biomarkers for depression. With a total of 2 patents, Kawamura's work focuses on developing methods for diagnosing and treating depression.

Latest Patents

Kawamura's latest patents include a method for treating depression using a biomarker. This method involves measuring the level of phosphoethanolamine in a blood sample collected from a subject. By comparing this level with a predetermined threshold, it can be determined if the subject requires treatment for depression. Additionally, he has developed a method for using low molecular weight compounds found in the body as biomarkers for diagnosing depression. This method utilizes various compounds, including ADP-ribose, ATP, serotonin, and phosphoethanolamine, among others.

Career Highlights

Throughout his career, Kawamura has worked with notable companies, including Human Metabolome Technologies, Inc. His research has been pivotal in advancing the understanding of depression and its biomarkers.

Collaborations

Kawamura has collaborated with esteemed colleagues such as Kosaku Shinoda and Yoshiaki Ohashi. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Noriyuki Kawamura's work in the field of depression biomarkers showcases his dedication to improving mental health diagnostics and treatment. His innovative patents and collaborations highlight his significant impact on this important area of research.